Recent News

NICE set to reject Janssen’s Darzalex for multiple myeloma

Janssen said it is extremely concerned that the National Institute for Health and Care Excellence has not recommended Darzalex for treatment of relapsed and refractory multiple myeloma in adults in preliminary guidelines.

Janssen

Original Link...


Tags: medical, MEDICINE, pharmaceuticals
0 Volde
Report        

Read On: